4.5 Article

MRI-compatible positioning device for guiding a focused ultrasound system for transrectal treatment of prostate cancer

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s11548-013-0964-x

Keywords

Prostate; MRI; Ultrasound

Funding

  1. European Community
  2. Research Promotion Foundation, under the EUROSTARS Cyprus Action of the EUREKA Cyprus Program [EUREKA/EUSTAR/0311/01]
  3. [PROFUS E! 6620]

Ask authors/readers for more resources

High-intensity focused ultrasound (HIFU) is a promising treatment method for many common cancers, including prostate cancer. Magnetic resonance image (MRI) guidance of HIFU permits targeting and monitoring of therapy. A prototype MRI-compatible positioning device that navigates a HIFU transducer was designed, fabricated and tested. The positioning device has two PC-controlled and one manually driven stage that allow endorectal access to the prostate. The positioning device was constructed using a 3-D rapid prototype manufacturing device. Software was developed that controls the motion of the positioning device and enables activation of a HIFU transducer. In vitro testing of the system was performed in a 1.5T MRI scanner using ex vivo turkey tissue. Optical encoders were employed to enhance the accuracy of this positioning device. The positioning device was successfully tested for MRI compatibility. The movement error of the positioning device is approximately 20 m. The robot has the ability to accurately move the transducer for creation of discrete and overlapping lesions. An MRI-compatible HIFU positioning system was developed that has the ability to create thermal lesions with MRI guidance for endorectal treatment of prostate cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available